Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.17 USD
-0.06 (-4.49%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.17 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.20 | 3.59% |
Earnings Summary
For their last quarter, Aclaris Therapeutics (ACRS) reported earnings of -$0.24 per share, beating the Zacks Consensus Estimate of $-0.28 per share. This reflects a positive earnings surprise of 14.29%. Look out for ACRS's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.20 per share, reflecting a year-over-year increase of 52.38%.
Earnings History
Price & Consensus
Zacks News for ACRS
BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Tops Revenue Estimates
ACRS: What are Zacks experts saying now?
Zacks Private Portfolio Services